Deal supported by Xplico

Bavarian Nordic Enters Licensing and Collaboration Agreement with Janssen for MVA-BN® in the Development of a Therapeutic HPV Vaccine.

By |December, 2015|Categories: Deal flow|0 Comments

Deal supported by Xplico

LEO Pharma to acquire global dermatology portfolio from Astellas.

By |November, 2015|Categories: Deal flow|0 Comments

Deal supported by Xplico

ObsEva and Kissei Pharmaceutical Announce Global Agreement to Develop and Commercialize KLH-2109 for the Treatment of Endometriosis.

By |November, 2015|Categories: Deal flow|0 Comments

Deal supported by Xplico

Sanofi and Lexicon Pharmaceuticals to Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes.

By |November, 2015|Categories: Deal flow|0 Comments

Deal supported by Xplico

Nuevolution Announces Drug Discovery Collaboration with Johnson & Johnson Innovation.

By |October, 2015|Categories: Deal flow|0 Comments

Deal supported by Xplico

PharmaMar announces license agreement with Specialised Therapeutics Australia Pty for
APLIDIN® (plitidepsin) in oncology.

By |August, 2015|Categories: Deal flow|0 Comments

Deal supported by Xplico

Inovio Pharmaceuticals enters into Strategic Cancer Vaccine Collaboration and License Agreement with MedImmune

By |August, 2015|Categories: Deal flow|0 Comments

Deal supported by Xplico

PharmaMar announces license agreement with TTY Biopharm for APLIDIN® (plitidepsin) in hematological cancers

By |July, 2015|Categories: Deal flow|0 Comments

Deal supported by Xplico

LEO Pharma Enters Supply and Distribution Agreement with NeoPharm on Non-Prescription Skin Care Solutions

By |June, 2015|Categories: Deal flow|0 Comments

Xplico launchs Xplico Consolidation – a company valuation tool to support funding & M&A activities

We are pleased to announce that we have released the first version of the Xplico Evaluator consolidation module Xplico Consolidation. The consolidation module enables you in a very easy way to get the company valuation […]

By |June, 2015|Categories: News|0 Comments